성기확대 RAMSEY, ISLE OF MAN--( / )--Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as Executive Chairman.
Dr Marshall brings over twenty years of business leadership to the company, with fifteen years at GSK culminating in his position as Vice President, Head of the Fibrosis & Lung Injury Discovery Performance Unit (DPU). Most recently, Dr Marshall was Senior Vice President, Global Development Head, Respiratory & Immunology of AstraZeneca. Dr Marshall was awarded a CBE in the 2021 Queen’s Honours List for his contribution to UK science and COVID-19.
“I am delighted that Dr Richard Marshall CBE, the former Senior Vice-President, Global Head of Development, Respiratory & Immunology at AstraZeneca, has agreed to lead Juvenescence as CEO. Throughout his career, Richard has been the architect of numerous transformative R&D strategies to drive innovation and deliver rapid growth, with a track record of collegial success, building high performing teams and developing novel therapies,” outgoing CEO Dr Gregory Bailey said. “Richard is a results-oriented leader who believes that in a post-COVID-19 world facing the impending crisis of an inverted demographic pyramid coupled with undercapitalized pension funds and ever-increasing healthcare costs, proactive, decentralized solutions are desperately needed. Juvenescence is a critical player in the mega-trends now driving towards the healthier lifestyles and digital health strategies needed to confront these issues. I am confident that with this appointment, we have a world class team with the experience and skillset to position Juvenescence as one of the premier biotech and pharmaceutical companies focused on modifying aging through prevention.”
Dr Richard Marshall CBE said, “I am thrilled to be joining Juvenescence at such a pivotal point in the company’s history. They are at a real inflection point, with an incredible opportunity to build on Juvenescence’s trusted brand and the Founders’ 30-year history of developing drugs to bring innovative approaches to modify and prevent the impact of aging to the market. With its broad portfolio and depth of experience, Juvenescence is building a unique ecosystem of key partnerships and acquiring the critical capabilities needed for success in this rapidly evolving field. I look forward to working with the team, our partners, and shareholders to capitalize on this incredible opportunity.”
About Juvenescence
Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan. It was founded by Jim Mellon, Dr Greg Bailey and Dr Declan Doogan. The Juvenescence team consists of highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering.
Juvenescence has a broad portfolio of products in development and is driving innovation, with a focus on discovering and developing these therapies to modify the aging process, through prevention and by regenerating damage, to support healthy aging and increase health span. The company is committed to inspiring and equipping the world to, not just reimagine what it means to age, but to help people Reimagine A Lifetime. For more information see:
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
SAN FRANCISCO--( / )--Andersen Global 산수유 SANits 스포츠토토 양귀비 Swiss 상림동홀덤펍 마왕 coverage through a Collaboration Agreement 상림동홀덤펍 남자정자 with Exactio, 스포츠토토 남자자격 adding further global mobility capabilities to the organization’s 스포츠토토 온라인릴천지 existing presence in the region.
Operating out of Basel and led 상림동홀덤펍 3D릴게임 by Managing Partners Per Melberg, Selim Bucher, Karin Verheijen and Alberto Perez, Exactio provides global mobility and professional services to both corporate and private clients. The firm’s team 스포츠토토 릴게임사이트정보 상림동홀덤펍 릴게임사이트정보 has over 75 years of combined experience working within the Swiss business landscape and specializes in international 상림동홀덤펍 릴천지주소 tax, payroll, social security compliance and employer reporting requirements.
“Our firm maintains strong relationships with our clients by delivering impactful and innovative solutions 스포츠토토 that meet their business needs,” 상림동홀덤펍 재갈 Karin said. “Collaborating 상림동홀덤펍 사설토토스포츠배팅 closely with the existing member firm and collaborating firm in Switzerland allows us to 스포츠토토 further expand our capabilities and provides the opportunity 스포츠토토 for growth as we are dedicated to providing the best-in-class service to our clients locally and globally.”
“Per, Karin and their team’s knowledge of the global mobility sector supports our commitment to provide our clients with holistic solutions globally and forecasts 스포츠토토 야마토연타 a synergistic working relationship 상림동홀덤펍 야마토정보제공 with our organization’s member firms and 상림동홀덤펍 야마토확률 collaborating firms,” said Andersen Global Chairman and Andersen CEO Mark Vorsatz. “This is a continued focus of our business to add more individual 스포츠토토 룸싸롱 cross-border services and expand our capabilities in assisting companies in this area. We will be formalizing a 상림동홀덤펍 룸살롱 structure for this service line in the near future.”
Andersen Global is an international association 스포츠토토 인터넷성인릴게임 of 상림동홀덤펍 인터넷다빈치 legally separate, independent member firms comprised of 스포츠토토 tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax 상림동홀덤펍 여성알바 LLC, Andersen Global now has more than 13,000 professionals worldwide and a presence in over 390 locations through its member firms and collaborating firms.
View source version on businesswire.com:Korea 상림동홀덤펍 pc야마토 Newswire distributes your news across every 상림동홀덤펍 SP연타 media channels through the industry’s largest press 스포츠토토 발기 release distribution network
추천바다껨,VIGRX,섹스하는장면,성인용품미타케구매쇼핑몰,밤도깨비,자위기구만들기,명기헤라수입,빛샘전자주식,lOBY,서노송동홀덤펍,신길4동화투치기,문래동2가홀덤대회,피그AV,꼬뽀넷
